<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
Pharmaceutical Product Development Inc. Consolidated Balance Sheet and Statement
of Operations included within this Form 10-Q and is qualified in its entirety by
reference to such financial statements.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> JUN-30-2000
<CASH> 62,791
<SECURITIES> 0
<RECEIVABLES> 114,623
<ALLOWANCES> 925
<INVENTORY> 0
<CURRENT-ASSETS> 197,096
<PP&E> 118,944
<DEPRECIATION> 61,175
<TOTAL-ASSETS> 298,507
<CURRENT-LIABILITIES> 86,930
<BONDS> 0
0
0
<COMMON> 2,492
<OTHER-SE> 205,989
<TOTAL-LIABILITY-AND-EQUITY> 298,507
<SALES> 0
<TOTAL-REVENUES> 165,810
<CGS> 0
<TOTAL-COSTS> 85,814
<OTHER-EXPENSES> 61,429
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 444
<INCOME-PRETAX> 21,595
<INCOME-TAX> 8,028
<INCOME-CONTINUING> 13,567
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 13,567
<EPS-BASIC> 0.55
<EPS-DILUTED> 0.54
</TABLE>